Halozyme Therapeutics, Inc. HALO
996 filings, 2 in the last 30 days
SEC filing indexWhat the 8-Ks said
5 events in the last 3 years: the officer, auditor, restatement, cyber, restructuring, listing, impairment and debt items. One line each, the filing's own words.
- Jul 2, 2026 CEO, CFO, COO or CAOCOO change “The company also announced the departure of Cortney Caudill as the Company’s Senior Vice President, Chief Operating Officer.” 8-K item 5.02 · all documents
- Apr 30, 2026 CEO, CFO, COO or CAOCFO change “(the “Company”) announced that Darren Snellgrove has been appointed to serve as the Company’s Chief Financial Officer (“CFO”), effective June 8, 2026.” 8-K item 5.02 · all documents
- Mar 12, 2026 CEO, CFO, COO or CAOCFO change “(the “Company”) announced that David Ramsay has been appointed to serve as the Company’s Interim Chief Financial Officer (“Interim CFO”), effective March 23, 2026.” 8-K item 5.02 · all documents
- Nov 24, 2025 CEO, CFO, COO or CAOCFO change “(“the Company”) announced a transition plan in which Nicole LaBrosse, Senior Vice President, Chief Financial Officer will continue to serve as the Company’s Chief Financial Officer until the earliest of when a new chief financial officer is hired, March 30, 2026 or such earlier date determined by the Company (the “Separation Date”) and then depart to pursue a new professional opportunity.” 8-K item 5.02 · all documents
- Nov 3, 2025 CEO, CFO, COO or CAOCFO change “The Company announced today a transition plan in which Nicole LaBrosse, Senior Vice President and Chief Financial Officer (“CFO”) will continue to serve as the Company’s CFO until the earlier of when a new chief financial officer is hired, or until March 30, 2026 (the “Separation Date”) and then depart to pursue a new professional opportunity.” 8-K item 5.02 · all documents
From the SEC filing index and the text of each 8-K. A line appears only when the 8-K names one of these items; for item 5.02 only a move of the CEO, CFO, COO or chief accounting officer. Older 8-Ks may have no text downloaded, so they show no quote.
Late filings, 8-K notices and going concern
None found in the last 2 years
-
Late filing notices (NT 10-K, NT 10-Q)No notice in the last 2 years.
-
8-K notices: listing, impairment, debt triggerNo item 3.01, 2.06 or 2.04 in the last 2 years.
-
Going-concern language in the 10-KNo statement of substantial doubt in the latest 10-K.
Facts to read in the filing, not a verdict: many companies with one of these carry on normally, and a company with neither can still have problems.
Every filing on one line
Each mark is a filing or an event in one; the bigger square is a 10-K. Hover for what it is, click to open it.
All 61 events
- Nov 14, 2026 SEC letter SEC asked 2 questions about Form 10-K for the Fiscal Year Ended December 31, 2014letters Oct 26, 2015 to Jan 28, 2016
- Nov 5, 2026 8-K Quarterly results8-K item 2.02
- Nov 5, 2026 10-Q Quarterly report (10-Q)period ended Sep 30, 2026
- Sep 30, 2026 8-K Director or officer change8-K item 5.02
- Sep 22, 2026 8-K Material agreement signed, New debt or obligation, Unregistered share sale8-K items 1.01, 2.03, 3.02
- Sep 18, 2026 8-K Other events8-K item 8.01
- Sep 16, 2026 Planned sale MATTHEW POSARD (Director) gave notice of a planned sale of 34,226 shares worth about $3.6MForm 144, approximate sale date Sep 16, 2026, under a 10b5-1 plan adopted Jun 15, 2026
- Sep 16, 2026 8-K Other events8-K item 8.01
- Aug 18, 2026 8-K Director or officer change8-K item 5.02
- Aug 17, 2026 Planned sale Helen Torley (President, CEO, Director) gave notice of a planned sale of 240,000 shares worth about $23.7MForm 144, approximate sale date Aug 17, 2026, under a 10b5-1 plan adopted Dec 3, 2025
- Aug 11, 2026 Planned sale CORTNEY A CAUDILL (Officer) gave notice of a planned sale of 41,702 shares worth about $4.3MForm 144, approximate sale date Aug 11, 2026
- Aug 10, 2026 Planned sale BERNADETTE CONNAUGHTON (Director) gave notice of a planned sale of 1,626 shares worth about $168KForm 144, approximate sale date Aug 10, 2026, under a 10b5-1 plan adopted May 29, 2025
- Aug 6, 2026 Planned sale Matthew Posard (Director) adopted a 10b5-1 trading planreported in the 10-Q, up to 49,102 shares, runs to Mar 31, 2027
- Aug 6, 2026 8-K Quarterly results8-K item 2.02
- Aug 6, 2026 10-Q Quarterly report (10-Q)period ended Jun 30, 2026
- Jul 2, 2026 Officer COO changeThe company also announced the departure of Cortney Caudill as the Company’s Senior Vice President, Chief Operating Officer.
- Jun 29, 2026 Planned sale MAHESH KRISHNAN (Director) gave notice of a planned sale of 7,304 shares worth about $548KForm 144, approximate sale date Jun 29, 2026, under a 10b5-1 plan adopted Mar 19, 2026
- May 15, 2026 Planned sale NICOLE LABROSSE (Former Officer) gave notice of a planned sale of 14,700 shares worth about $987KForm 144, approximate sale date May 15, 2026
- May 11, 2026 Planned sale Helen Torley (President, CEO, Director) gave notice of a planned sale of 101,923 shares worth about $6.5MForm 144, approximate sale date May 11, 2026, under a 10b5-1 plan adopted Mar 21, 2025
- May 11, 2026 Planned sale Mahesh Krishnan (Director) adopted a 10b5-1 trading planreported in the 10-Q, up to 7,304 shares, runs to Jun 1, 2027
- May 11, 2026 8-K Quarterly results8-K item 2.02
- May 11, 2026 10-Q Quarterly report (10-Q)period ended Mar 31, 2026
- May 7, 2026 8-K Shareholder vote results8-K item 5.07
- May 1, 2026 Planned sale BERNADETTE CONNAUGHTON (Director) gave notice of a planned sale of 4,875 shares worth about $310KForm 144, approximate sale date May 1, 2026, under a 10b5-1 plan adopted May 29, 2025
- Apr 30, 2026 Officer CFO change(the “Company”) announced that Darren Snellgrove has been appointed to serve as the Company’s Chief Financial Officer (“CFO”), effective June 8, 2026.
- Apr 24, 2026 8-K Bylaws or fiscal year changed8-K item 5.03
- Mar 12, 2026 Officer CFO change(the “Company”) announced that David Ramsay has been appointed to serve as the Company’s Interim Chief Financial Officer (“Interim CFO”), effective March 23, 2026.
- Mar 10, 2026 Planned sale CORTNEY A CAUDILL (Officer) gave notice of a planned sale of 8,857 shares worth about $599KForm 144, approximate sale date Mar 10, 2026
- Mar 9, 2026 Planned sale CORTNEY A CAUDILL (Officer) gave notice of a planned sale of 20,000 shares worth about $1.4MForm 144, approximate sale date Mar 9, 2026
- Feb 17, 2026 Planned sale Nicole LaBrosse (Senior Vice President and Chief Financial Officer) ended a 10b5-1 trading planreported in the 10-K, up to 17,110 shares
- Feb 17, 2026 Planned sale Helen Torley (President and Chief Executive Officer) adopted a 10b5-1 trading planreported in the 10-K, up to 700,000 shares, runs to Jul 30, 2027
- Feb 17, 2026 8-K Quarterly results8-K item 2.02
- Feb 17, 2026 10-K Annual report (10-K)period ended Dec 31, 2025
- Feb 3, 2026 Planned sale Helen Torley (President, CEO, Director) gave notice of a planned sale of 150,000 shares worth about $11.2MForm 144, approximate sale date Feb 3, 2026, under a 10b5-1 plan adopted Mar 21, 2025
- Jan 28, 2026 8-K Quarterly results8-K item 2.02
- Jan 5, 2026 Planned sale BERNADETTE CONNAUGHTON (Director) gave notice of a planned sale of 2,000 shares worth about $141KForm 144, approximate sale date Jan 5, 2026, under a 10b5-1 plan adopted May 29, 2025
- Dec 9, 2025 8-K Director or officer change8-K item 5.02
- Dec 8, 2025 8-K Director or officer change8-K item 5.02
- Nov 24, 2025 Officer CFO change(“the Company”) announced a transition plan in which Nicole LaBrosse, Senior Vice President, Chief Financial Officer will continue to serve as the Company’s Chief Financial Officer until the earliest of when a new chief financial officer is hired, March 30, 2026 or such earlier date determined by the Company (the “Separation Date”) and then depart to pursue a new professional opportunity.
- Nov 12, 2025 8-K Material agreement signed, New debt or obligation, Unregistered share sale8-K items 1.01, 2.03, 3.02
- Nov 7, 2025 8-K Other events8-K item 8.01
- Nov 5, 2025 8-K Material agreement signed, New debt or obligation, Other events8-K items 1.01, 2.03, 8.01
- Nov 3, 2025 Officer CFO changeThe Company announced today a transition plan in which Nicole LaBrosse, Senior Vice President and Chief Financial Officer (“CFO”) will continue to serve as the Company’s CFO until the earlier of when a new chief financial officer is hired, or until March 30, 2026 (the “Separation Date”) and then depart to pursue a new professional opportunity.
- Nov 3, 2025 10-Q Quarterly report (10-Q)period ended Sep 30, 2025
- Oct 14, 2025 8-K Regulation FD disclosure8-K item 7.01
- Oct 6, 2025 8-K Director or officer change8-K item 5.02
- Oct 3, 2025 8-K Material agreement signed8-K item 1.01
- Oct 1, 2025 8-K Regulation FD disclosure8-K item 7.01
- Aug 5, 2025 Planned sale Bernadette Connaughton (Director) adopted a 10b5-1 trading planreported in the 10-Q, up to 17,330 shares, runs to Aug 31, 2026
- Aug 5, 2025 Planned sale Nicole LaBrosse (Senior Vice President and Chief Financial Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 17,110 shares, runs to Apr 22, 2026
- Aug 5, 2025 8-K Quarterly results8-K item 2.02
- Aug 5, 2025 10-Q Quarterly report (10-Q)period ended Jun 30, 2025
- May 6, 2025 Planned sale Helen Torley (President and Chief Executive Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 251,923 shares
- May 6, 2025 8-K Quarterly results8-K item 2.02
- May 6, 2025 10-Q Quarterly report (10-Q)period ended Mar 31, 2025
- May 2, 2025 8-K Shareholder vote results8-K item 5.07
- Mar 21, 2025 8-K Director or officer change8-K item 5.02
- Feb 18, 2025 8-K Quarterly results8-K item 2.02
- Feb 18, 2025 10-K Annual report (10-K)period ended Dec 31, 2024
- Feb 13, 2025 8-K Director or officer change8-K item 5.02
- Jan 8, 2025 8-K Quarterly results8-K item 2.02
From the SEC filing index. Insider purchases go back 180 days (the Form 4s downloaded).
Every filing
Newest first, by kind · each form links to sec.gov
| Filed | Form | What it is |
|---|---|---|
| Nov 5, 2026 | 10-Q | Quarterly report |
| Nov 5, 2026 | 8-K | Quarterly results |
| Oct 8, 2026 | 4 | Insider trade |
| Oct 8, 2026 | 4/A | Insider trade (amended) |
| Oct 2, 2026 | 4 | Insider trade |
| Oct 2, 2026 | 3 | New insider |
| Oct 2, 2026 | 4 | Insider trade |
| Sep 30, 2026 | 8-K | Director or officer change |
| Sep 22, 2026 | 8-K | Material agreement signed, New debt or obligation, Unregistered share sale |
| Sep 18, 2026 | 8-K | Other events |
| Sep 17, 2026 | 4 | Insider trade |
| Sep 16, 2026 | 144 | Notice of planned insider sale |
| Sep 16, 2026 | 8-K | Other events |
| Sep 11, 2026 | 4 | Insider trade |
| Sep 2, 2026 | 4 | Insider trade |
| Aug 21, 2026 | 3 | New insider |
| Aug 19, 2026 | 4 | Insider trade |
| Aug 18, 2026 | 8-K | Director or officer change |
| Aug 17, 2026 | 144 | Notice of planned insider sale |
| Aug 11, 2026 | 144 | Notice of planned insider sale |
| Aug 11, 2026 | 4 | Insider trade |
| Aug 10, 2026 | 144 | Notice of planned insider sale |
| Aug 6, 2026 | 10-Q | Quarterly report |
| Aug 6, 2026 | 8-K | Quarterly results |
| Jul 9, 2026 | 4 | Insider trade |
| Jul 2, 2026 | 4 | Insider trade |
| Jul 2, 2026 | 4 | Insider trade |
| Jul 2, 2026 | 4 | Insider trade |
| Jul 2, 2026 | 8-K | Director or officer change |
| Jun 30, 2026 | 4 | Insider trade |
| Jun 29, 2026 | 144 | Notice of planned insider sale |
| Jun 15, 2026 | 4 | Insider trade |
| Jun 9, 2026 | 3 | New insider |
| Jun 3, 2026 | 4 | Insider trade |
| Jun 2, 2026 | 4 | Insider trade |
| May 15, 2026 | 144 | Notice of planned insider sale |
| May 13, 2026 | 4 | Insider trade |
| May 11, 2026 | 144 | Notice of planned insider sale |
| May 11, 2026 | 10-Q | Quarterly report |
| May 11, 2026 | 8-K | Quarterly results |
| May 7, 2026 | 4 | Insider trade |
| May 7, 2026 | 4 | Insider trade |
| May 7, 2026 | 4 | Insider trade |
| May 7, 2026 | 4 | Insider trade |
| May 7, 2026 | 4 | Insider trade |
| May 7, 2026 | 4 | Insider trade |
| May 7, 2026 | 8-K | Shareholder vote results |
| May 5, 2026 | 4 | Insider trade |
| May 1, 2026 | 144 | Notice of planned insider sale |
| Apr 30, 2026 | SCHEDULE 13G | 5%+ owner (passive) |
| Apr 30, 2026 | 8-K | Director or officer change |
| Apr 24, 2026 | 8-K | Bylaws or fiscal year changed |
| Apr 7, 2026 | 4 | Insider trade |
| Apr 2, 2026 | 4 | Insider trade |
| Apr 2, 2026 | 4 | Insider trade |
| Mar 27, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Mar 23, 2026 | 3 | New insider |
| Mar 23, 2026 | ARS | Annual report to shareholders |
| Mar 23, 2026 | DEFA14A | Extra proxy material |
| Mar 23, 2026 | DEF 14A | Proxy statement |
| Mar 12, 2026 | 8-K | Director or officer change |
| Mar 10, 2026 | 144 | Notice of planned insider sale |
| Mar 10, 2026 | 4 | Insider trade |
| Mar 9, 2026 | 144 | Notice of planned insider sale |
| Mar 4, 2026 | 4 | Insider trade |
| Feb 24, 2026 | 4 | Insider trade |
| Feb 24, 2026 | 4 | Insider trade |
| Feb 24, 2026 | 4 | Insider trade |
| Feb 24, 2026 | 4 | Insider trade |
| Feb 17, 2026 | 4 | Insider trade |
| Feb 17, 2026 | 4 | Insider trade |
| Feb 17, 2026 | 4 | Insider trade |
| Feb 17, 2026 | 10-K | Annual report |
| Feb 17, 2026 | 8-K | Quarterly results |
| Feb 11, 2026 | 4 | Insider trade |
| Feb 11, 2026 | 4 | Insider trade |
| Feb 11, 2026 | 4 | Insider trade |
| Feb 11, 2026 | 4 | Insider trade |
| Feb 5, 2026 | 4 | Insider trade |
| Feb 3, 2026 | 144 | Notice of planned insider sale |
| Jan 28, 2026 | 8-K | Quarterly results |
| Jan 6, 2026 | 4 | Insider trade |
| Jan 6, 2026 | 4 | Insider trade |
| Jan 6, 2026 | 4 | Insider trade |
| Jan 5, 2026 | 144 | Notice of planned insider sale |
| Jan 5, 2026 | 3 | New insider |
| Dec 19, 2025 | 4 | Insider trade |
| Dec 11, 2025 | 4 | Insider trade |
| Dec 9, 2025 | 8-K | Director or officer change |
| Dec 8, 2025 | 8-K | Director or officer change |
| Dec 1, 2025 | 4 | Insider trade |
| Dec 1, 2025 | 4 | Insider trade |
| Nov 24, 2025 | 8-K | Director or officer change |
| Nov 18, 2025 | S-8 | Shares registered for employee plans |
| Nov 12, 2025 | 8-K | Material agreement signed, New debt or obligation, Unregistered share sale |
| Nov 12, 2025 | 4 | Insider trade |
| Nov 12, 2025 | 4 | Insider trade |
| Nov 7, 2025 | 8-K | Other events |
| Nov 5, 2025 | 8-K | Material agreement signed, New debt or obligation, Other events |
| Nov 3, 2025 | 10-Q | Quarterly report |
Show the other 75 filings on this page
Press releases with quarterly results are attached to the 8-Ks marked "Quarterly results"; read them on Earnings releases.
Sources
SEC's filing index (data.sec.gov submissions). Each form links to the document on sec.gov.
Also
Earnings releases: the text of each quarter's results release. Statements by period: the income statement, balance sheet or cash flow of the last filings side by side.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/HALO/export.csv") into a cell.